+

Help Us Enhance Your NephU Experience

User experience form

Email Address*(Required)

What is Your Specialty?*(Required)

Select all that apply (Select at least one)*

What are your goals for visiting NephU?(Required)

Learn about IgAN MOD and disease progression

Join the NephU community

Access additional IgAN resources

Select all that apply (Select at least one)*

How would you like to hear from us?(Required)

Biweekly Email Newsletters

Schedule a Meeting with a Medical Science Liaison

Learn About Upcoming Live/Virtual Events

Agree(Required)

By providing your name, email address, and other information, you are giving Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and companies working with OPDC permission to send you information from NephU. OPDC will not sell or transfer your name, address, or email address. You agree that should you use any material provided through NephU, you will attribute the source of that information to “NephU sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc.” For additional information, please read our Privacy Policy. By submitting your information, you agree to the terms provided above, and the terms provided in our Terms of Use and our Privacy Policy.

*Required Field

Rare Kidney Diseases (PKD, IgAN, & Others)

There are several rare kidney diseases including Polycystic Kidney Disease (PKD) and IgA Nephropathy (IgAN) that can affect the health of the kidney and lead to kidney failure. Rare kidney disease conditions range from relatively common conditions to very rare syndromes and can have a known or unknown genetic cause.

Editors Picks

1 to 10 of 172 Next »

Breakdown of the MEST-C Score in IgA Nephropathy

Audio/Podcast November 12, 2024

This podcast provides an in-depth review of the Oxford MEST-C score, focusing on its practical application in diagnosing and prognosticating IgA Nephropathy. Read More

Role of the Renal Pathologist in IgA Nephropathy

On-Demand Webinar November 6, 2024

Through the lens of renal pathology, this webinar will provide insights into the histopathological features that are crucial for accurate diagnosis and risk stratification in IgA Nephropathy, highlighting the significance… Read More

Kidney Transplant In Patients With IgA Nephropathy (IgAN)

Infographic October 16, 2024

Learn about issues relating to kidney transplantation and IgAN. Read More

Utilization of the International IgA Nephropathy Prediction Tool

On-Demand Webinar October 8, 2024

Learn about the clinical, laboratory and histological risk predictors that make up the International IgAN Prediction Tool and gain an understanding of its clinical utility and future potential. Read More

Risk of Progression to ESKD in IgA Nephropathy

Infographic October 7, 2024

This infographic highlights the risk of progression to ESKD, including in patients traditionally considered low risk. Read More

Overview of IgAN

Infographic October 7, 2024

This infographic focuses on IgAN diagnosis, prognosis, and disease management strategies. Read More

APRIL & the 4-Hit Pathogenic Cascade of IgAN

Infographic October 7, 2024

This infographic highlights the role of APRIL in a pre-hit 1 step that drives the 4-hit cascade.1 References 1. Mathur M, et al. J Clin Med. 2023;12(21):6927. Read More

Women’s Health in Polycystic Kidney Disease (PKD) – A Focus on Pregnancy & Family Planning

On-Demand Webinar October 1, 2024

In this webinar, Dr. Niloofar Nobakht will provide an overview of ADPKD as a genetically inherited disease and describe the burden of ADPKD as it pertains to women of child-bearing… Read More

What’s New in ADPKD: Delving into Depression/Mental Health

Audio/Podcast September 20, 2024

In this episode, we will take a deep dive into depression in ADPKD including the prevalence, impact on patient’s quality of life, effective strategies to manage depression and how we… Read More

Mental Health In Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Infographic September 17, 2024

Learn how ADPKD can affect quality of life and psychosocial well-being. Read More

1 to 10 of 172 Next »

NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.

May 2020 MRC2.CORP.X.04767

August 2024 US.CORP.X.24.00265

Now Leaving NephU

This link will take you outside of the NephU community website.

You are attempting to log out of NephU, please confirm.

NephU

Sorry, this content is no longer available.

Help Us Enhance Your NephU Experience

Rare Kidney Diseases (PKD, IgAN, & Others)

Editors Picks